FIELD: medicine.
SUBSTANCE: in patient's venous blood antigens of locus A and B of HLA system are defined. In case if double-locus haplotypes HLA-A2/B35 and/or A10/B35, and/or A19/B16 and/or A19/B35 are detected, high risk of development of pollen bronchial asthma is predicted. If double-locus haplotypes HLA-A2/B7 and/or A3/B7 and/or A11/B7 are present, resistance to development of pollen bronchial asthma is predicted.
EFFECT: method application makes it possible to increase accuracy of prediction of development of pollen bronchial asthma.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING POLLINOSIS DEVELOPMENT | 2010 |
|
RU2430360C1 |
| METHOD FOR PREDICTION OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2441242C1 |
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
| METHOD FOR TREATMENT AND PREVENTION OF ALLERGIC SPECTRUM STATES | 2016 |
|
RU2635968C1 |
| METHOD FOR TREATMENT ATOPIC ALLERGIC DISEASES | 0 |
|
SU1695925A1 |
| METHOD FOR PROGNOSTICATING PREDISPOSITION TO DIABETIC FETOPATHY | 0 |
|
SU1807406A1 |
| ELECTRIC PUNCTURE METHOD FOR DIAGNOSING ALLERGY | 1994 |
|
RU2113167C1 |
| METHOD FOR ALLERGIC DISEASE TREATMENT | 0 |
|
SU1793923A3 |
| METHOD FOR PHENOTYPE DETERMINATION OF CHRONIC INFLAMMATORY DISEASES OF NOSE AND PARANASAL SINUSES IN CASE OF INDICATIONS FOR TARGETED THERAPY | 2023 |
|
RU2826780C1 |
| METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
